Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus (Q34407893)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
scientific article

    Statements

    Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus (English)
    0 references
    0 references
    0 references
    Atsunori Kashiwagi
    Kenichi Kazuta
    Satoshi Yoshida
    Itsuro Nagase
    28 November 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit